Responding to Bufomix Claims – Symbicort Positioning

Bufomix Claim

Symbicort Response

1

Symbicort requires 60 L/min minimal inhalation flow

Misconception. Symbicort Turbohaler is effective from &gt;30 L/min, making it sultable for a wide range of patients, including those with compromised lung function.

2

Butomix must be stored in a plastic cover to maintain stability

This raises concerns about product stability in real-world use, especially in humid environments. Symbicort has proven environmental resilience and no such packaging constraint.

3

Bufomix requires simple shaking

Incorrect handling (e.g., not shaking vertically) may lead to dose inconsistency, Symbicort requires no shaking, ensuring simple, consistent dosing.

4

Bufomix can be misused with coordination

Turbohaler is a true DPI (breath-actuated) with no need for coordination; reducing misuse risk. Bufomix may be confused with MDIs, especially in multi-device patients’.

5

Double-clicking Bufomix affects dose accuracy

Bufomix can deliver more or less than 1 dose if clicked twice. Symbicort ensures one reliable dose per actuation, with a built-in dose counter for accuracy.

Sympicort V.s. Bufomix